Agilon Health, Inc. (AGL)

NYSE • Healthcare

$89.77

-$2.82 (-3.1%)

Market closed

Last close at September 11, 2026 at 20:00 UTC

Open$94.71

Day Range$88.87 - $97.22

Avg. Volume (3M)204.1K

Market Cap$1.4B

52 Week Range

$7.48$133.04

Next EarningsIn 51 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$1.4B100%

Gross Profitminus cost of goods$107.1M7%

Operating Incomeminus R&D and overhead$11.7M1%

Net Incomeminus taxes and the rest$17.9M1%

In plain terms: out of every $100 in revenue, Agilon Health, Inc. keeps $1 as net profit.

Fundamentals & Financials

Revenue (TTM)

$5.9B

Net Income (TTM)

-$251.1M

EPS (TTM)

-$15.38

ROA (TTM)

-15.78%

Current Ratio

1.08

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

-127.3%Q3 2025-$6.25

-80.7%Q4 2025-$6.75

-70.4%Q1 2026-$11.5

+59.3%Q2 2026$1.8

+622.2%Q3 2026$1.04

Nov 3

in 51 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +622.2%

Agilon Health’s revenue topped consensus in the second fiscal quarter of 2026, reported Aug. 5, as revenue rose roughly 7% to about $1.5 billion from $1.39 billion a year earlier and beat the $1.45 billion estimate by about 3%. Operating cash flow was negative $33.6 million.

View full earnings history

About Agilon Health, Inc.

Agilon Health, Inc. (NYSE: AGL) provides healthcare solutions for older adults in the United States through local primary care physicians. The company operates in healthcare services tied to care delivery within the Medical - Care Facilities business, and generated $5.9 billion in revenue in FY2025.

Name

Agilon Health, Inc.

CEO

Timothy O'Rourke

Website

agilonhealth.com

Industry

Healthcare

Year Founded

2016

Employees

856

Today's Snapshot

AI-generated

AGL closed 3.2% lower at 89.64, while its sector was flat. Volume was about two-thirds of its usual level.

Trading Volume

Below 10d avg (182.9K)

127.4K

vs S&P 500 Today

Strong Underperformance

-4.12%

Updated: September 11, 2026 at 20:06 UTC

Technical Indicators

2 Buy3 Neutral3 Sell

Trading near $89.77, AGL presents a neutral profile driven by mixed signals across timeframes: short-term averages sit near the current price while medium-term averages remain lower and long-term averages are supportive, producing no clear directional bias. Momentum measures are slightly negative and RSI is below neutral, yet trend strength is weak and volatility is elevated, which together indicate indecision rather than conviction. Volume trends are soft and the pivot sits above the market, offering a nearby resistance reference. Technical takeaway: Neutral.

All signals

EMA (5 indicators)$60.02 - $93.95
Sell
RSI (14)45.01
Neutral
Stochastic %K (14, 3, 3)55.51
Neutral
MACD Level (12, 26)-2.11
Neutral

Peers & Related Assets

ANNXAnnexon, Inc.

$3.94-4.8%

LRMRLarimar Therapeutics, Inc.

$3.92+1.8%

SLPSimulations Plus, Inc.

$18.420.0%

DHDefinitive Healthcare Corp.

$1.05+1.9%

SOPHSOPHiA GENETICS S.A.

DBVTDBV Technologies S.A.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.